Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Xultophy Patients nave to basal insulin or a GLP-1 agonist: starting dose is 10 units once daily Patients currently on basal insulin or a GLP-1 agonist: starting dose is 16 units once daily Maintenance: titrate dose up or down by 2 units once or twice weekly, depending on blood sugar goals Missed doses: resume dosing at the next scheduled dose
Descriptive statistics were utilized to summarize demographic information and clinical factor data
Medicare rules give beneficiaries the right to request a formulary exception a formal appeal asking the plan to cover a drug that isnt on its formulary (or to cover it at a lower cost tier)
Barth syndrome Barth syndrome, an X-linked mitochondrial disorder, is characterized by a clinical triad of cardiomyopathy, skeletal myopathy, and neutropenia, along with aberrant cristae morphology and respiratory chain abnormalities
The researchers further reported that common GLP-1 gastrointestinal side effects, such as nausea and vomiting, were mostly mild to moderate and temporary